Olivier BOUSIGES

Associate professor

University of Strasbourg

France

Research Interests

Explore related searches

Professors in France

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Olivier Bousiges is an Associate Professor at Université de Strasbourg in France. His research primarily focuses on dementia, particularly the diagnostic and biomarker aspects of Alzheimer's disease and dementia with Lewy bodies. Recent publications highlight his work on passive immunization in early-stage amyloid pathology and the involvement of ApoE4 in dementia. Additionally, he explores clinical reporting and the differential diagnostics of cerebrospinal fluid biomarkers in these neurodegenerative conditions.

Articles (10)

Year:

2025

Year:

2024

Year:

2023

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Year:

2021

Year:

2020

Year:

2020

Collaborators (6)

Céline Héraud

University of Strasbourg

FRANCE

View details

Mari DeMarco

Clinical Professor

The University of British Columbia

CANADA

View details

Blanc Frédéric

FRANCE

View details

Véronique Kemmel

University of Strasbourg

FRANCE

View details

aurelie bedel

MCU-PH, Associate professor and clinician

FRANCE

View details

Anne FOGLI

Université Clermont Auvergne

FRANCE

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Olivier BOUSIGES

Research Interests

Explore related searches

Contact this professor

About

Articles (10)

Passive immunization against amyloid peptide restores pattern separation deficits in early stage of amyloid pathology but not in normal aging

Diagnostic value of CSF chromogranin A to discriminate between Alzheimer's disease and dementia with Lewy bodies

Involvement of ApoE4 in dementia with Lewy bodies in the prodromal and demented stages: evaluation of the Strasbourg cohort

Biomarkers of Dementia with Lewy Bodies: Differential Diagnostic with Alzheimer’s Disease

Biomarkers and diagnosis of dementia with Lewy bodies including prodromal: Practical aspects

Clinical reporting following the quantification of cerebrospinal fluid biomarkers in Alzheimer's disease: An international overview

CSF in Epileptic Prodromal Alzheimer's Disease: No Diagnostic Contribution but a Pathophysiological One

Association of cerebral microbleeds with cerebrospinal fluid Alzheimer‐biomarkers and clinical symptoms in early dementia with Lewy bodies

Differential diagnostic value of total alpha-synuclein assay in the cerebrospinal fluid between Alzheimer’s disease and dementia with Lewy bodies from the prodromal stage

The combined effect of amyloid-β and tau biomarkers on brain atrophy in dementia with Lewy bodies.

Collaborators (6)

Céline Héraud

Mari DeMarco

Blanc Frédéric

Véronique Kemmel

aurelie bedel

Anne FOGLI

Make your next move.